---
title: 'Efficacy and safety of pasireotide treatment in acromegaly: A systematic review
  and single arm meta-analysis'
date: '2024-09-30'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39349787/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241001183409&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: Pasireotide demonstrates biochemical control in patients
  with active or uncontrolled acromegaly. Although a high rate of hyperglycemic adverse
  events and diabetes mellitus related to the treatment were observed, most of them
  were ...'
disable_comments: true
---
CONCLUSION: Pasireotide demonstrates biochemical control in patients with active or uncontrolled acromegaly. Although a high rate of hyperglycemic adverse events and diabetes mellitus related to the treatment were observed, most of them were ...